⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
EVGN News
EVOGENE LTD.
Evogene Schedules Third Quarter 2025 Financial Results Release
prnewswire.com
EVGN
Evogene Announces Acute Graft-Versus-Host Disease (aGVHD) as the Target Indication for Its Internal AI-Driven Drug Discovery Program
prnewswire.com
EVGN
Evogene to Participate in Upcoming BIO-Europe in Germany and Drug Discovery Chemistry Europe in Spain
prnewswire.com
EVGN